Cargando…

Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: a cross-sectional study

INTRODUCTION: Contraceptive use among HIV-infected women in Togo is poorly documented. We aim at assessing the prevalence of modern contraceptive use and associated factors among HIV-infected women in Togo. DESIGN: Cross-sectional study. SETTING: The study was conducted in five HIV care centres in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaya, Issifou, Patassi, Akouda Akessiwè, Landoh, Dadja Essoya, Bignandi, Essodjèlouna Manani, Kolani, Kanfitine, Namoro, Abdel-Daim Daou, Patchali, P’Niwè Massoubayo, Djalogue, Lihanimpo, Ekouevi, Didier Koumavi, Saka, Bayaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922471/
https://www.ncbi.nlm.nih.gov/pubmed/29691241
http://dx.doi.org/10.1136/bmjopen-2017-019006
_version_ 1783318199789420544
author Yaya, Issifou
Patassi, Akouda Akessiwè
Landoh, Dadja Essoya
Bignandi, Essodjèlouna Manani
Kolani, Kanfitine
Namoro, Abdel-Daim Daou
Patchali, P’Niwè Massoubayo
Djalogue, Lihanimpo
Ekouevi, Didier Koumavi
Saka, Bayaki
author_facet Yaya, Issifou
Patassi, Akouda Akessiwè
Landoh, Dadja Essoya
Bignandi, Essodjèlouna Manani
Kolani, Kanfitine
Namoro, Abdel-Daim Daou
Patchali, P’Niwè Massoubayo
Djalogue, Lihanimpo
Ekouevi, Didier Koumavi
Saka, Bayaki
author_sort Yaya, Issifou
collection PubMed
description INTRODUCTION: Contraceptive use among HIV-infected women in Togo is poorly documented. We aim at assessing the prevalence of modern contraceptive use and associated factors among HIV-infected women in Togo. DESIGN: Cross-sectional study. SETTING: The study was conducted in five HIV care centres in the Centrale and Kara regions in Togo. PARTICIPANTS: We included 461 HIV-positive women aged between 15 and 49 years and who were sexually active. MAIN OUTCOME MEASURE: The outcome variable was HIV-infected women who were using modern contraceptive methods. RESULTS: A total of 461 HIV-infected women were interviewed, with an average age of 34.3 (±7.1). Among them, 332 (73.1%) women reported using contraceptive methods, mostly condom alone (74.7%) or in combination with hormonal contraceptive (16.9%). In multivariate analysis, education level (primary: adjusted OR (aOR)=1.99, 95% CI (1.05 to 3.76); secondary level and higher: aOR=3.95, 95% CI (2.03 to 7.67)), WHO clinical stage (stage II: aOR=0.7, 95% CI (0.37 to 1.33)), follow-up in private care facilities (aOR=2.54, 95% CI (1.22 to 5.29)) and having a child (aOR=2.51, 95% CI (1.41 to 4.5)) were associated with higher contraceptive use, while marital status (living in union: aOR=0.45, 95% CI (0.28 to 0.74)) and WHO stages III and IV (aOR=0.47, 95% CI (0.24 to 0.94)) were associated with lower contraceptive use. CONCLUSION: About three-quarters of sexually active HIV-infected women in Togo were using contraceptive methods, and private health facilities favoured this contraceptive use. It is important to strengthen the implementation of interventions to increase the incentives for HIV-infected women to use contraception in Togo.
format Online
Article
Text
id pubmed-5922471
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-59224712018-04-30 Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: a cross-sectional study Yaya, Issifou Patassi, Akouda Akessiwè Landoh, Dadja Essoya Bignandi, Essodjèlouna Manani Kolani, Kanfitine Namoro, Abdel-Daim Daou Patchali, P’Niwè Massoubayo Djalogue, Lihanimpo Ekouevi, Didier Koumavi Saka, Bayaki BMJ Open HIV/AIDS INTRODUCTION: Contraceptive use among HIV-infected women in Togo is poorly documented. We aim at assessing the prevalence of modern contraceptive use and associated factors among HIV-infected women in Togo. DESIGN: Cross-sectional study. SETTING: The study was conducted in five HIV care centres in the Centrale and Kara regions in Togo. PARTICIPANTS: We included 461 HIV-positive women aged between 15 and 49 years and who were sexually active. MAIN OUTCOME MEASURE: The outcome variable was HIV-infected women who were using modern contraceptive methods. RESULTS: A total of 461 HIV-infected women were interviewed, with an average age of 34.3 (±7.1). Among them, 332 (73.1%) women reported using contraceptive methods, mostly condom alone (74.7%) or in combination with hormonal contraceptive (16.9%). In multivariate analysis, education level (primary: adjusted OR (aOR)=1.99, 95% CI (1.05 to 3.76); secondary level and higher: aOR=3.95, 95% CI (2.03 to 7.67)), WHO clinical stage (stage II: aOR=0.7, 95% CI (0.37 to 1.33)), follow-up in private care facilities (aOR=2.54, 95% CI (1.22 to 5.29)) and having a child (aOR=2.51, 95% CI (1.41 to 4.5)) were associated with higher contraceptive use, while marital status (living in union: aOR=0.45, 95% CI (0.28 to 0.74)) and WHO stages III and IV (aOR=0.47, 95% CI (0.24 to 0.94)) were associated with lower contraceptive use. CONCLUSION: About three-quarters of sexually active HIV-infected women in Togo were using contraceptive methods, and private health facilities favoured this contraceptive use. It is important to strengthen the implementation of interventions to increase the incentives for HIV-infected women to use contraception in Togo. BMJ Publishing Group 2018-04-24 /pmc/articles/PMC5922471/ /pubmed/29691241 http://dx.doi.org/10.1136/bmjopen-2017-019006 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle HIV/AIDS
Yaya, Issifou
Patassi, Akouda Akessiwè
Landoh, Dadja Essoya
Bignandi, Essodjèlouna Manani
Kolani, Kanfitine
Namoro, Abdel-Daim Daou
Patchali, P’Niwè Massoubayo
Djalogue, Lihanimpo
Ekouevi, Didier Koumavi
Saka, Bayaki
Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: a cross-sectional study
title Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: a cross-sectional study
title_full Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: a cross-sectional study
title_fullStr Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: a cross-sectional study
title_full_unstemmed Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: a cross-sectional study
title_short Modern contraceptive use among HIV-infected women attending HIV care centres in Togo: a cross-sectional study
title_sort modern contraceptive use among hiv-infected women attending hiv care centres in togo: a cross-sectional study
topic HIV/AIDS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922471/
https://www.ncbi.nlm.nih.gov/pubmed/29691241
http://dx.doi.org/10.1136/bmjopen-2017-019006
work_keys_str_mv AT yayaissifou moderncontraceptiveuseamonghivinfectedwomenattendinghivcarecentresintogoacrosssectionalstudy
AT patassiakoudaakessiwe moderncontraceptiveuseamonghivinfectedwomenattendinghivcarecentresintogoacrosssectionalstudy
AT landohdadjaessoya moderncontraceptiveuseamonghivinfectedwomenattendinghivcarecentresintogoacrosssectionalstudy
AT bignandiessodjelounamanani moderncontraceptiveuseamonghivinfectedwomenattendinghivcarecentresintogoacrosssectionalstudy
AT kolanikanfitine moderncontraceptiveuseamonghivinfectedwomenattendinghivcarecentresintogoacrosssectionalstudy
AT namoroabdeldaimdaou moderncontraceptiveuseamonghivinfectedwomenattendinghivcarecentresintogoacrosssectionalstudy
AT patchalipniwemassoubayo moderncontraceptiveuseamonghivinfectedwomenattendinghivcarecentresintogoacrosssectionalstudy
AT djaloguelihanimpo moderncontraceptiveuseamonghivinfectedwomenattendinghivcarecentresintogoacrosssectionalstudy
AT ekouevididierkoumavi moderncontraceptiveuseamonghivinfectedwomenattendinghivcarecentresintogoacrosssectionalstudy
AT sakabayaki moderncontraceptiveuseamonghivinfectedwomenattendinghivcarecentresintogoacrosssectionalstudy